HCP
60
-2
ED
50
-3
WAT
61
2
WDC
63
2
EIX
74
-3
KO
42
-4
CMS
55
-6
PPL
52
-7
SPG
56
-7
JWN
53
5
FMC
46
12
NDAQ
57
-5
AMG
50
-7
GS
72
-6
AIZ
78
-4
M
46
18
FOX
50
-14
INTU
53
-3
GOOGL
54
3
HBAN
57
-3
HCP
60
-2
ED
50
-3
WAT
61
2
WDC
63
2
EIX
74
-3
KO
42
-4
CMS
55
-6
PPL
52
-7
SPG
56
-7
JWN
53
5
FMC
46
12
NDAQ
57
-5
AMG
50
-7
GS
72
-6
AIZ
78
-4
M
46
18
FOX
50
-14
INTU
53
-3
GOOGL
54
3
HBAN
57
-3
Financhill
Back

Sandoz Group AG 10K Form

Sell
38

SDZNY
Sandoz Group AG

Last Price:
43.89
Seasonality Move:
6.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SDZNY News And Ratings

See the #1 stock for the next 7 days that we like better than SDZNY

SDZNY Financial Statistics

Sales & Book Value

Annual Sales: $9.98B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 2.26

Profitability

EPS (TTM): 1.64000
Net Income (TTM): $353.45M
Gross Margin: $4.56B
Return on Equity: 0%
Return on Assets: 0%

Sandoz Group AG Earnings Forecast

Key Sandoz Group AG Financial Ratios

  • The Gross Profit Margin over the past 2 years for SDZNY is 45.74%.
  • The Selling, General & Administrative Expenses for SDZNY have been equal to 23.94% of Gross Profit Margin.
  • The Research & Development expenses have been 9.28% of Revenue.
  • The Interest Expense is 262.34% of Operating Income.
  • The Net Earning history of SDZNY is 0.77% of Total Revenues.
  • Per Share Earnings over the last 2 years have been positive in 0 years.

Sandoz Group AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SDZNY
Website: sandoz.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 243.89
Forward P/E Ratio: 0

SDZNY Technical Analysis vs Fundamental Analysis

Sell
38
Sandoz Group AG (SDZNY) is a Sell

Is Sandoz Group AG a Buy or a Sell?

  • Sandoz Group AG stock is rated a Sell
    The current Sandoz Group AG [SDZNY] share price is $43.90. The Score for SDZNY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.